Work

Deviation from expected cognitive ability across psychotic disorders

Year: 2017

Type: article

Study design: Observational Study

Source: Schizophrenia Research

DOI: 10.1016/j.schres.2017.05.019

Authors: W.C. Hochberger, T. Combs, J.L. Reilly, J.R. Bishop, R.S.E. Keefe, B.A. Clementz, M.S. Keshavan, G.D. Pearlson, C.A. Tamminga, S.K. Hill, J.A. Sweeney

Institutions: Rosalind Franklin University of Medicine and Science, Northwestern University, University of Minnesota, Duke University, University of Georgia, Harvard University, Yale University, The University of Texas Southwestern Medical Center, University of Cincinnati

Language: English

Topic: Schizophrenia research and treatment

Subfield: Psychiatry and Mental health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: National Institutes of Health, National Institute of Mental Health, National Center for Advancing Translational Sciences

Awards: G1044130170, Schizophrenia Pharmacogenetics: cognition and symptom response to antipsychotics, G208937423, G2241124166, G2273952854, 1/5 Bipolar-Schizophrenia Network for Intermediate Phenotypes 2 (B-SNIP 2) - Resu, G2458313802, G4136061041, G4863277230, G4991243177, G5246119025, G568434048, G5926081180, G6528626969, G661573911, 3/5 Bipolar-Schizophrenia Network for Intermediate Phenotypes 2 (BSNIP-2), Yale Clinical and Translational Science Award

OpenAlex ID: W2620099622

FWCI: 3.182

Cites: 41

Cited by: 28

Related to: 10